Pericellular proteolysis by leukocytes and tumor cells on substrates: Focal activation and the role of urokinase-type plasiminogen activator

Histochemistry and Cell Biology

Volumn 121, Issue 4, 2004, Pages 299-310

  Kindzelskii, Andrei L ^a   Amhad, Imran ^a   Keller, Donald ^a   Zhou, M J ^a   Haugland, Richard P ^b   Garni Wagner, B A ^a   Gyetko, Margaret R ^a   Todd, Robert F ^a   Petty, Howard R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MOLECULAR PROBES INC   (United States)

Author keywords

Adhesion; Neutrophils; Plasminogen activator; Proteolysis; Tumor cells

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CELL ADHESION; CELL MIGRATION; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; LAMELLIPODIUM; LEUKOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELLS, CULTURED; ENDOPEPTIDASES; FLUORESCENT DYES; FOCAL ADHESIONS; HUMANS; LEUKOCYTES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NEOPLASMS; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 2442505682     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-004-0639-3     Document Type: Article

References (59)

1. Artym VV, Petty HR (2002) Molecular proximity of Kv1.3 voltage-gated potassium channels and β1-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol 120:29-37
2. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Eng J Med 298:659-725
3. Bajpai A, Baker JB (1985) Cryptic urokinase binding sites on human foreskin fibroblasts. Biochem Biophys Res Com 133:475-482
4. Bianchi E, Cohen RL, Thor AT, Todd RF, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866
5. Blasi F (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111
6. 2-integrins, and src-kinases within a single receptor complex of human monocytes. J Exp Med 181:1381-1390
7. Campbell EJ, Campbell MA (1988) Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J Cell Biol 106:667-676
8. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd III RF, Boxer LA, Petty HR (1995) Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type 3 and calcium. J Immunol 154:1817-1829
9. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degan J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424
10. Coopman PJ, Thomas DM, Gehlen KR, Mueller SC (1996) Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol Biol Cell 7:1789-1804
11. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD (1993) Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A 90:5021-5025
12. Estreicher A, Muhlhauser J, Carpentier J-L, Orci L, Vassalli JD (1990) The receptor for urokinase-type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783-792
13. Farmer WH, Yuan Z (1991) A continuous fluorescent assay for measuring protease activity using natural protein substrate. Anal Biochem 197:347-352
14. Fazioli F, Blasi F (1994) Urokinase type plasminogen activator and its receptor: new targets for anti-metastatic therapy. Trends Pharmacol 15:25-29
15. Gadd SJ, Majdic O, Casinrerk W, Stockinger H, Maurer D, Eher R, Knapp W (1990) M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen. Clin Exp Immunol 80:252-256
16. Granelli-Piperno A, Vassalli JD, Reich E (1977) Secretion of plasminogen activator by human polymorphonuclear leukocytes: modulation by glucocorticoids and other effectors. J Exp Med 146:1693-1706
17. Gyetko M, Webb A, Sitrin R (1988) Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U937 mononuclear phagocytes. J Immunol 141:2693-2698
18. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG (1994) The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93:1380-1387
19. Hafeman DG, Seul M, Cliffe CM, McConnell HM (1984) Superoxide enhances photobleaching during cellular immune attack against fluorescent lipid monolayer membranes. Biochim Biophys Acta 772:20-28
20. Hearing VJ, Law LW, Corti A, Appella E, Blasi F (1988) Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 48:1270-1278
21. Herbert CA, Baker JB (1988) Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J Cell Biol 106:1241-1247
22. Hed J (1977) The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1:357-361
23. Hormer KA, Beighton D (1990) Fluorometric determination of bacterial protease activity using fluorescein isothiocyanate-labeled proteins as substrates. Anal Biochem 191:133-137
24. 2) during neutrophil polarization. J Immunol 156:297-309
25. Kindzelskii AL, Ahmad I, Anderson D, Zhou MJ, Haugland RP, Mizukami I, Gyetko M, Todd III RF, Petty HR (1996b) Urokinase-type plasminogen activator receptors (uPAR) focus substrate proteolysis by neutrophils and tumor cells. FASEB J 10:A1333
26. Kindzelskii AL, Eszes MM, Todd III RF, Petty HR (1997) Proximity oscillations of complement receptor type 4 and urokinase receptors on migrating neutrophils. Biophys J 73:1777-1784
27. Kindzelskii AL, Zhou MJ, Haugland RP, Boxer LA, Petty HR (1998) Oscillatory pericellular proteolysis and oxidant deposition during neutrophil locomotion. Biophys J 74:90-97
28. Kirchheimer JC, Remold HG (1989) Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol 143:2634-2639
29. Krause JC, Poo H, Xue W, Mayo-Bond L, Todd III RF, Petty HR (1994) Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing both Fcγ receptor IIIB and the complement receptor type 3. J Immunol 153:1769-1777
30. Kummer JA, Avvink JJ, DeBoer JP, Roem D, Nieuwenhuya EJ, Kamp AM, Swaak TJG, Hack CE (1992) Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum 35:884-893
31. Lakowicz JR (1983) Principles of fluorescence spectroscopy, chap 9. Plenum, New York
32. Liou G, Campbell EJ (1996) Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol 157:2624-2631
33. Min HY, Semnani R, Mizukami IF, Watt K, Todd III RF, Liu DY (1992) cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol 148:3636-3642
34. Mizukami IF, Vinjamuri SD, Trochelman RD, Todd III RF (1991a) A structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J Immunol 144:1841-1848
35. Mizukami IF, Vinjamuri SD, Perini F, Liu DY, Todd III RF (1991b) Purification, biochemical characterization, and biosynthesis of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J Immunol 147:1331-1337
36. Mueller SC, Yeh Y, Chen WT (1992) Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol 119:1309-1325
37. Mulligan RC, Berg P (1981) Selection for animal cells that express Escherichi coli gene coding for xanthine-guanine-phosphoribosyl-transferase. Proc Natl Acad Sci U S A 78:2072-2076
38. Nash AD, Uren S, Hawes CS, Boyle W (1989) Application of a novel immunization protocol to the production of monoclonal antibodies specific for macrophages in human placenta. Immunology 68:332-340
39. Ossowski L, Reich E (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611-619
40. Ossowski L, Russo-Payne H, Wilson EL (1991) Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in nude mice. Cancer Res 51:274-281
41. Petty HR (1993) Molecular biology of membranes. Plenum, New York
42. Petty HR, Todd III RF (1996) Integrins as promiscuous signal transduction devices. Immunol Today 17:209-212
43. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K (1991) Cellular receptor for urokinase plasminogen activator carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 266:1926-1933
44. Pollanen J, Saksela O, Salonen E-M, Andreasen P, Neilsen L, Dano K, Vaheri A (1987) Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085-1096
45. Pollanen J, Hedman K, Nielsen LS, Dano K, Vaheri A (1988) Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol 106:87-95
46. Saksela O, Rifkin DB (1988) Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
47. Sameni M, Moin K, Sloane BF (2000) Imaging proteolysis by living human breast cancer cells. Neoplasia 2:496-504
48. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L, Chapman HA (1996) Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 88:3185-3194
49. Sitrin RG, Todd III RF, Petty HR, Brock TG, Shollenberger SB, Albrecht E, Gyetko MR (1996) The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 97:1942-1951
50. Springer TA (1990) The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 6:359-402
51. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798
52. Takahashi K, Ikeo K, Gojobori T, Tanifuji M (1990) Local function of urokinase receptor at the adhesion contact sites of metastatic tumor cell. Thrombosis Res Suppl X:55-61
53. Todd RF III, Barnathan ES, Bohsulav J, Chapman HA, Cohen RL, Felez J, Howell A, Johnson JG, Knapp W, Kramer M, Miles LA, Nykjaer A, Ralfkilear E, Shchuren E (1995) CD87 Cluster workshop report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds) Leucocyte typing V. Oxford University Press, Oxford, UK, pp 932-939
54. Twining SS (1984) Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal Biochem 143:30-34
55. Vassalli JD, Hamilton J, Reich E (1976) Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell 8:271-281
56. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA (1996) Regulation of integrin function by urokinase receptor. Science 273:1551-1555
57. Xue W, Kindzelskii AL, Todd III RF, Petty HR (1994) Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol 152:4630-4640
58. Xue W, Garni-Wagner BA, Todd III RF, Petty HR (1997) Urokinase-type plasminogen activator receptor is physically associated with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res 57:1682-1689
59. Zar JH (1984) Biostatistical analysis. Prentice-Hall, Englewood Cliffs, NJ, pp 121-129